Literature DB >> 34183835

Engineered yeast tune down gut inflammation.

Mark Mimee1, Cathryn R Nagler2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34183835     DOI： 10.1038/s41591-021-01420-8

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  1 in total

1.  Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease.

Authors:  Benjamin M Scott; Cristina Gutiérrez-Vázquez; Liliana M Sanmarco; Jessica A da Silva Pereira; Zhaorong Li; Agustín Plasencia; Patrick Hewson; Laura M Cox; Madelynn O'Brien; Steven K Chen; Pedro M Moraes-Vieira; Belinda S W Chang; Sergio G Peisajovich; Francisco J Quintana
Journal:  Nat Med       Date:  2021-06-28       Impact factor: 53.440
  1 in total
  3 in total

Review 1.  Exploration of the link between gut microbiota and purinergic signalling.

Authors:  MingJian Li; BoWen Liu; Rong Li; Ping Yang; Ping Leng; Yong Huang
Journal:  Purinergic Signal       Date:  2022-09-19       Impact factor: 3.950

2.  Engineered yeast-based eATP precisely controlled system for the treatment of inflammatory bowel disease.

Authors:  Adnan Hassan Tahir; Yong Tang
Journal:  Purinergic Signal       Date:  2022-01-17       Impact factor: 3.950

3.  Exodus: sequencing-based pipeline for quantification of pooled variants.

Authors:  Ilya Vainberg-Slutskin; Noga Kowalsman; Yael Silberberg; Tal Cohen; Jenia Gold; Edith Kario; Iddo Weiner; Inbar Gahali-Sass; Sharon Kredo-Russo; Naomi B Zak; Merav Bassan
Journal:  Bioinformatics       Date:  2022-05-12       Impact factor: 6.931
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.